despite evidence of progressive declines in fev1 with increasing ( but subirritant ) doses of mdi on three consecutive days , there was no bronchial hyperresponsiveness to methacholine , before or after mdi challenge .
C0085129
bronchial hyperresponsiveness
C0600370
methacholine